BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 31462078)

  • 1. Gut Microbiome and Response to Cardiovascular Drugs.
    Tuteja S; Ferguson JF
    Circ Genom Precis Med; 2019 Sep; 12(9):421-429. PubMed ID: 31462078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advances in host-microbe metabolic axis].
    Pi Y; Gao K; Zhu W
    Wei Sheng Wu Xue Bao; 2017 Feb; 57(2):161-9. PubMed ID: 29750478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding connections and roles of gut microbiome in cardiovascular diseases.
    Rajendiran E; Ramadass B; Ramprasath V
    Can J Microbiol; 2021 Feb; 67(2):101-111. PubMed ID: 33079568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of metabolic potential of human gut microbiome in human nutrition.
    Yadav M; Verma MK; Chauhan NS
    Arch Microbiol; 2018 Mar; 200(2):203-217. PubMed ID: 29188341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Reactions: Breaking Down Xenobiotic-Microbiome Interactions.
    Clarke G; Sandhu KV; Griffin BT; Dinan TG; Cryan JF; Hyland NP
    Pharmacol Rev; 2019 Apr; 71(2):198-224. PubMed ID: 30890566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of gut microbiota in the pharmacokinetics of antihypertensive drugs.
    Choi MS; Yu JS; Yoo HH; Kim DH
    Pharmacol Res; 2018 Apr; 130():164-171. PubMed ID: 29391236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of an in vitro gut microbiome biotransformation platform with chlorogenic acid as model compound: From fecal sample to biotransformation product identification.
    Mortelé O; Iturrospe E; Breynaert A; Verdickt E; Xavier BB; Lammens C; Malhotra-Kumar S; Jorens PG; Pieters L; van Nuijs ALN; Hermans N
    J Pharm Biomed Anal; 2019 Oct; 175():112768. PubMed ID: 31398630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gut microbiome and cardiovascular disease: current knowledge and clinical potential.
    Ahmad AF; Dwivedi G; O'Gara F; Caparros-Martin J; Ward NC
    Am J Physiol Heart Circ Physiol; 2019 Nov; 317(5):H923-H938. PubMed ID: 31469291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Untapped potential of gut microbiome for hypertension management.
    Gao K; Wang PX; Mei X; Yang T; Yu K
    Gut Microbes; 2024; 16(1):2356278. PubMed ID: 38825779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyphenols' Gut Microbiota Metabolites: Bioactives or Biomarkers?
    Tomas-Barberan FA; Selma MV; Espín JC
    J Agric Food Chem; 2018 Apr; 66(14):3593-3594. PubMed ID: 29558130
    [No Abstract]   [Full Text] [Related]  

  • 11. The Role of the Gut Microbiome on Chronic Kidney Disease.
    Sampaio-Maia B; Simões-Silva L; Pestana M; Araujo R; Soares-Silva IJ
    Adv Appl Microbiol; 2016; 96():65-94. PubMed ID: 27565581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of the Gut Microbiome in Hypertension.
    Yan Q; Gu Y; Li X; Yang W; Jia L; Chen C; Han X; Huang Y; Zhao L; Li P; Fang Z; Zhou J; Guan X; Ding Y; Wang S; Khan M; Xin Y; Li S; Ma Y
    Front Cell Infect Microbiol; 2017; 7():381. PubMed ID: 28884091
    [No Abstract]   [Full Text] [Related]  

  • 13. The Host Shapes the Gut Microbiota via Fecal MicroRNA.
    Liu S; da Cunha AP; Rezende RM; Cialic R; Wei Z; Bry L; Comstock LE; Gandhi R; Weiner HL
    Cell Host Microbe; 2016 Jan; 19(1):32-43. PubMed ID: 26764595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling the environmental and genetic interactions in atherosclerosis: Central role of the gut microbiota.
    Org E; Mehrabian M; Lusis AJ
    Atherosclerosis; 2015 Aug; 241(2):387-99. PubMed ID: 26071662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiota-drug interactions: Impact on metabolism and efficacy of therapeutics.
    Wilkinson EM; Ilhan ZE; Herbst-Kralovetz MM
    Maturitas; 2018 Jun; 112():53-63. PubMed ID: 29704918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the Chemical Lexicon of Host-Gut Microbiota Interactions.
    Nicolas GR; Chang PV
    Trends Pharmacol Sci; 2019 Jun; 40(6):430-445. PubMed ID: 31079848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human gut microbiome - a new and exciting avenue in cardiovascular drug discovery.
    Du Y; Li X; Su C; Wang L; Jiang J; Hong B
    Expert Opin Drug Discov; 2019 Oct; 14(10):1037-1052. PubMed ID: 31315489
    [No Abstract]   [Full Text] [Related]  

  • 18. Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy.
    Mancini A; Campagna F; Amodio P; Tuohy KM
    Food Funct; 2018 Mar; 9(3):1373-1388. PubMed ID: 29485654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human gut microbiota plays a role in the metabolism of drugs.
    Jourova L; Anzenbacher P; Anzenbacherova E
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Sep; 160(3):317-26. PubMed ID: 27485182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complex interplay of diet, xenobiotics, and microbial metabolism in the gut: Implications for clinical outcomes.
    Taguer M; Maurice CF
    Clin Pharmacol Ther; 2016 Jun; 99(6):588-99. PubMed ID: 26950037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.